Early research (Phase 1)Study completedNCT05260437
What this trial is testing
Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants
Who this might be right for
COVID-19SARS-CoV-2
GlaxoSmithKline 99